Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
McKinsey
Farmers Insurance
Baxter
Johnson and Johnson
Fish and Richardson
Daiichi Sankyo
Medtronic
US Department of Justice

Generated: April 23, 2018

DrugPatentWatch Database Preview

FLOMAX Drug Profile

« Back to Dashboard

When do Flomax patents expire, and what generic alternatives are available?

Flomax is a drug marketed by Boehringer Ingelheim and is included in one NDA.

The generic ingredient in FLOMAX is tamsulosin hydrochloride. There are thirty-three drug master file entries for this compound. Forty-one suppliers are listed for this compound. Additional details are available on the tamsulosin hydrochloride profile page.
Drug patent expirations by year for FLOMAX
Pharmacology for FLOMAX
Synonyms for FLOMAX
(-)-(R)-5-(2-((2-(o-Ethoxyphenoxy)ethyl)amino)propyl)-2-methoxybenzenesulfonamide monohydrochloride
(-)-LY 253352
(-)-ly253352
()-(R)-5-(2-((2-(O-ethoxyphenoxy)ethyl)amino)propyl)-2-methoxybenzenesulfonamide monohydrochloride
(R)-(-)-YM12617;LY253351
(R)-5-(2-((2-(2-ETHOXYPHENOXY)ETHYL)AMINO)PROPYL)-2-METHOXYBENZENESULFONAMIDE HCL
(R)-5-(2-((2-(2-Ethoxyphenoxy)ethyl)amino)propyl)-2-methoxybenzenesulfonamide hydrochloride
(R)-5-(2-((2-(2-ethoxyphenoxy)ethyl)amino)propyl)-2-methoxybenzenesulfonamide monohydrochloride
(R)-5-(2-(2-(2-ethoxyphenoxy)ethylamino)propyl)-2-methoxybenzenesulfonamide hydrochloride
(R)-Tamsulosin Hydrochloride
106138-88-9 (Parent)
106463-17-6
112101-78-7
11SV1951MR
128332-25-2
463T176
5-[(2R)-2-[[2-(-Ethoxyphenoxy)ethyl]amino]propyl]-2-methoxybenzenesulfonamide Hydrochloride
5-[(2R)-2-[[2-(2-Ethoxyphenoxy)ethyl]amino]propyl]-2-benzenesulfonamide hydrochloride
5-[(2R)-2-[[2-(2-Ethoxyphenoxy)ethyl]amino]propyl]-2-methoxybenzenesulfonamide hydrochloride
5-[(2R)-2-[2-(2-ethoxyphenoxy)ethylamino]propyl]-2-methoxy-benzenesulfonamide hydrochloride
5-[(2R)-2-[2-(2-ethoxyphenoxy)ethylamino]propyl]-2-methoxybenzenesulfonamide hydrochloride
5-[(2R)-2-[2-(2-ethoxyphenoxy)ethylamino]propyl]-2-methoxybenzenesulfonamide;hydrochloride
5-[(2R)-2-{[2-(2-ethoxyphenoxy)ethyl]amino}propyl]-2-methoxybenzenesulfonamide hydrochloride
5-[(R)-2-[2-(2-Ethoxyphenoxy)ethylamino]propyl]]-2-methoxybenzenesulfonamide Hydrochloride
AB0013408
AC1NSFXI
AK124398
AKOS015895342
AKOS015995287
Alna
AlnaOCAS
Amsulosin hydrochloride
Amsulosin Hydrochloride;Tamsulosin hydrochloride
AN-10809
API0001417
BCP0726000042
Benzenesulfonamide, 5-(2-((2-(2-ethoxyphenoxy)ethyl)amino)propyl)-2-methoxy-, monohydrochloride, (R)-
Benzenesulfonamide, 5-(2-((2-(2-ethoxyphenoxy)ethyl)amino)propyl)-2-methoxy-,monohydrochloride, (R)-
BG0475
Bio-0146
BS-1019
C20H28N2O5S.HCl
C20H29ClN2O5S
CAS-106463-17-6
CC-34638
CHEBI:9399
CHEMBL1200914
CS-2897
D01024
DSSTox_CID_26628
DSSTox_GSID_46628
DSSTox_RID_81777
DTXSID2046628
EU-617
Expros
Flomax MR
FT-0631038
FT-0674803
H991
Harnal
Harnal (TN)
Harnalidge OCAS
HY-B0661A
I14-8827
Josir
KB-60669
KS-00000H3T
LS-31577
LY-253351
LY253351
MFCD00922997
MLS003899197
MolPort-006-069-199
MP-0769
NCGC00167442-01
NCGC00167442-03
Omic
Omix
Omnic
OR156791
Pradif
PubChem18241
Q-201777
R-(-)-5-(2-((2-(2-Ethoxyphenoxy)ethyl)amino)propyl)-2-methoxybenzenesulfonamide hydrochloride
R-(-)-YM-12617
R-()-5-(2-((2-(2-Ethoxyphenoxy)ethyl)amino)propyl)-2-methoxybenzenesulfonamide hydrochloride
RTX-011084
s4729
SC-17028
SCHEMBL23428
Secotex
SMR002543366
ST24026438
Tamsulosin (hydrochloride)
Tamsulosin HCl
TAMSULOSIN HYDROCHLORIDE
Tamsulosin hydrochloride (JP17/USAN)
Tamsulosin hydrochloride [USAN:JAN]
Tamsulosin hydrochloride [USAN:USP:JAN]
Tamsulosin hydrochloride, >=98% (HPLC)
Tamsulosin hydrochloride, European Pharmacopoeia (EP) Reference Standard
Tamsulosin hydrochloride, pharmaceutical secondary standard; traceable to USP, PhEur and BP
Tamsulosin hydrochloride, United States Pharmacopeia (USP) Reference Standard
tamsulosin.HCl
Tamsulosina hydrochloride
tamsulosine hydrochloride
Tamsulosinum hydrochloride
Tox21_112446
Tox21_112446_1
UNII-11SV1951MR
Urolosin
Y-617
YM 12617-1
YM 617
YM-12617-1
YM-617
YM617
Yutanal
ZZIZZTHXZRDOFM-XFULWGLBSA-N

US Patents and Regulatory Information for FLOMAX

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Boehringer Ingelheim FLOMAX tamsulosin hydrochloride CAPSULE;ORAL 020579-001 Apr 15, 1997 AB RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for FLOMAX

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Boehringer Ingelheim FLOMAX tamsulosin hydrochloride CAPSULE;ORAL 020579-001 Apr 15, 1997 ➤ Try a Free Trial ➤ Try a Free Trial
Boehringer Ingelheim FLOMAX tamsulosin hydrochloride CAPSULE;ORAL 020579-001 Apr 15, 1997 ➤ Try a Free Trial ➤ Try a Free Trial
Boehringer Ingelheim FLOMAX tamsulosin hydrochloride CAPSULE;ORAL 020579-001 Apr 15, 1997 ➤ Try a Free Trial ➤ Try a Free Trial
Boehringer Ingelheim FLOMAX tamsulosin hydrochloride CAPSULE;ORAL 020579-001 Apr 15, 1997 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Paragraph IV (Patent) Challenges for FLOMAX
Drugname Dosage Strength RLD Submissiondate
➤ Subscribe Capsules 0.4 mg ➤ Subscribe 2004-12-20

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Julphar
Farmers Insurance
US Army
Citi
Cipla
McKinsey
Healthtrust
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.